1. Home
  2. FLY vs HALO Comparison

FLY vs HALO Comparison

Compare FLY & HALO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

FLY

Firefly Aerospace Inc.

N/A

Current Price

$38.25

Market Cap

7.9B

Sector

Industrials

ML Signal

N/A

Logo Halozyme Therapeutics Inc.

HALO

Halozyme Therapeutics Inc.

HOLD

Current Price

$69.85

Market Cap

8.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FLY
HALO
Founded
2017
1998
Country
United States
United States
Employees
1409
N/A
Industry
Military/Government/Technical
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.9B
8.8B
IPO Year
N/A
2001

Fundamental Metrics

Financial Performance
Metric
FLY
HALO
Price
$38.25
$69.85
Analyst Decision
Buy
Buy
Analyst Count
9
11
Target Price
$38.88
$78.64
AVG Volume (30 Days)
8.3M
1.7M
Earning Date
05-04-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
1.22
Revenue
N/A
$151,862,000.00
Revenue This Year
$174.79
$28.24
Revenue Next Year
$66.73
$12.56
P/E Ratio
N/A
$57.23
Revenue Growth
N/A
N/A
52 Week Low
$16.00
$51.06
52 Week High
$62.17
$82.22

Technical Indicators

Market Signals
Indicator
FLY
HALO
Relative Strength Index (RSI) 46.30 59.01
Support Level $18.95 $67.94
Resistance Level $48.28 $70.93
Average True Range (ATR) 5.11 2.07
MACD -1.16 0.10
Stochastic Oscillator 8.35 90.84

Price Performance

Historical Comparison
FLY
HALO

About FLY Firefly Aerospace Inc.

Firefly Aerospace Inc is a space and defense technology company with an established track record of success providing comprehensive mission solutions to national security, government, and commercial customers. The company develops and provides space and defense technologies, including launch vehicles and spacecraft systems, supporting launch, transit, and in-orbit operations for government, commercial, and national security customers. It has only one operating segment. The majority of the company's revenue is derived from Spacecraft Solutions.

About HALO Halozyme Therapeutics Inc.

Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.

Share on Social Networks: